leflunomide has been researched along with Anemia in 4 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To estimate the incidence of pancytopenia in patients taking leflunomide with or without methotrexate in Australia." | 7.74 | The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate. ( Calcino, LJ; Hill, RL; McEwen, J; Purcell, PM; Riley, CG, 2007) |
| "Rheumatoid arthritis is a chronic disease of the joints, which causes joint pain and disability." | 5.48 | Treatment with either leflunomide or adalimumab reduces anaemia in patients with rheumatoid arthritis. ( Colares, VLP; Fernandes, AMR; Fernandes, ES; Martins, MMRS; Mendes, SJF; Monteiro, CRAV; Muniz, TF; Pereira, DMS; Pereira, ICP; Silva, BLR; Sousa, NCF, 2018) |
| "To estimate the incidence of pancytopenia in patients taking leflunomide with or without methotrexate in Australia." | 3.74 | The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate. ( Calcino, LJ; Hill, RL; McEwen, J; Purcell, PM; Riley, CG, 2007) |
| "Rheumatoid arthritis is a chronic disease of the joints, which causes joint pain and disability." | 1.48 | Treatment with either leflunomide or adalimumab reduces anaemia in patients with rheumatoid arthritis. ( Colares, VLP; Fernandes, AMR; Fernandes, ES; Martins, MMRS; Mendes, SJF; Monteiro, CRAV; Muniz, TF; Pereira, DMS; Pereira, ICP; Silva, BLR; Sousa, NCF, 2018) |
| "The prednisone dose was reduced by a mean of 25% in these same 13 patients." | 1.31 | Experiences with leflunomide in solid organ transplantation. ( Brady, L; Chong, A; Huang, W; Jensik, S; Kottayil, A; Longstreth, J; Millis, M; Mital, D; Williams, JW, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pereira, ICP | 1 |
| Sousa, NCF | 1 |
| Pereira, DMS | 1 |
| Mendes, SJF | 1 |
| Muniz, TF | 1 |
| Colares, VLP | 1 |
| Silva, BLR | 1 |
| Monteiro, CRAV | 1 |
| Martins, MMRS | 1 |
| Fernandes, AMR | 1 |
| Fernandes, ES | 1 |
| Wang, H | 1 |
| Sun, L | 1 |
| Tan, W | 1 |
| McEwen, J | 1 |
| Purcell, PM | 1 |
| Hill, RL | 1 |
| Calcino, LJ | 1 |
| Riley, CG | 1 |
| Williams, JW | 1 |
| Mital, D | 1 |
| Chong, A | 1 |
| Kottayil, A | 1 |
| Millis, M | 1 |
| Longstreth, J | 1 |
| Huang, W | 1 |
| Brady, L | 1 |
| Jensik, S | 1 |
4 other studies available for leflunomide and Anemia
| Article | Year |
|---|---|
Treatment with either leflunomide or adalimumab reduces anaemia in patients with rheumatoid arthritis.
Topics: Adalimumab; Adult; Anemia; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Humans; Isoxazoles; | 2018 |
Clinical features of children with pulmonary microscopic polyangiitis: report of 9 cases.
Topics: Adolescent; Anemia; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Child; Child, | 2015 |
The incidence of pancytopenia in patients taking leflunomide alone or with methotrexate.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; An | 2007 |
Experiences with leflunomide in solid organ transplantation.
Topics: Anemia; Calcineurin Inhibitors; Creatinine; Humans; Immunosuppressive Agents; Isoxazoles; Kidney Tra | 2002 |